Cornerstone Capital Management Holdings’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$14.4M Buy
45,202
+1,955
+5% +$627K 0.1% 223
2017
Q3
$13.5M Sell
43,247
-20,459
-32% -$6.06M 0.11% 224
2017
Q2
$17.3M Sell
63,706
-31,870
-33% -$8.43M 0.14% 174
2017
Q1
$26.1M Sell
95,576
-5,698
-6% -$1.61M 0.2% 104
2016
Q4
$28.7M Sell
101,274
-2,792
-3% -$828K 0.22% 93
2016
Q3
$32.6M Buy
104,066
+23,294
+29% +$6.9M 0.24% 69
2016
Q2
$19.5M Buy
80,772
+10,119
+14% +$2.67M 0.16% 130
2016
Q1
$18.4M Sell
70,653
-28,631
-29% -$7.56M 0.15% 138
2015
Q4
$30.4M Buy
99,284
+184
+0.2% +$52.9K 0.25% 67
2015
Q3
$28.9M Sell
99,100
-2,000
-2% -$660K 0.27% 63
2015
Q2
$40.8M Sell
101,100
-5,300
-5% -$2.13M 0.36% 46
2015
Q1
$44.9M Buy
106,400
+1,854
+2% +$731K 0.42% 41
2014
Q4
$35.5M Buy
104,546
+23,180
+28% +$7.5M 0.36% 43
2014
Q3
$26.9M Buy
81,366
+22,956
+39% +$7.57M 0.29% 70
2014
Q2
$18.4M Sell
58,410
-1,504
-3% -$453K 0.2% 135
2014
Q1
$18.3M Sell
59,914
-8,920
-13% -$2.83M 0.21% 122
2013
Q4
$19.2M Sell
68,834
-31,715
-32% -$8.2M 0.22% 117
2013
Q3
$24.2M Buy
100,549
+13,146
+15% +$2.94M 0.29% 69
2013
Q2
$18.8M Buy
+87,403
New +$18.7M 0.23% 107

Other funds holding BIIB

Cornerstone Capital Management Holdings's BIIB Position: Q4 2017 in Review

Cornerstone Capital Management Holdings increased its Biogen (BIIB) stake by 4.5% in Q4 2017, buying an estimated $627K and bringing the position to 45,202 shares worth $14.4M. The position accounts for 0.1% of the portfolio, ranked #223.

Cornerstone Capital Management Holdings first reported a position in BIIB in Q2 2013 and has held it in 19 quarters since. The position peaked at $44.9M in Q1 2015. 1,122 funds tracked by Wall St. Rank hold BIIB as of Q4 2017.

  • Cornerstone Capital Management Holdings held 45,202 shares of Biogen worth $14.4M as of Q4 2017.
  • Cornerstone Capital Management Holdings bought 1,955 Biogen shares in Q4 2017, an estimated $627K.
  • Biogen made up 0.1% of Cornerstone Capital Management Holdings's portfolio in Q4 2017, its #223 holding.
  • Cornerstone Capital Management Holdings first reported a position in Biogen in Q2 2013 and has held it in 19 quarters since.
  • Cornerstone Capital Management Holdings's Biogen position peaked at $44.9M in Q1 2015.
  • 1,122 funds tracked by Wall St. Rank held Biogen as of Q4 2017.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.